Biodistribution and post-therapy dosimetric analysis of [(177)Lu]Lu-DOTA(ZOL) in patients with osteoblastic metastases: first results

BACKGROUND: Preclinical biodistribution and dosimetric analysis of [(177)Lu]Lu-DOTA(ZOL) suggest the bisphosphonate zoledronate as a promising new radiopharmaceutical for therapy of bone metastases. We evaluated biodistribution and normal organ absorbed doses resulting from therapeutic doses of [(17...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:EJNMMI Res
Main Authors: Khawar, Ambreen, Eppard, Elisabeth, Roesch, Frank, Ahmadzadehfar, Hojjat, Kürpig, Stefan, Meisenheimer, Michael, Gaertner, Florian. C., Essler, Markus, Bundschuh, Ralph. A.
Formato: Artigo
Idioma:Inglês
Publicado: Springer Berlin Heidelberg 2019
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6882969/
https://ncbi.nlm.nih.gov/pubmed/31781962
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13550-019-0566-x
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares